ALEXANDRIA, Va., Jan. 13 -- United States Patent no. 12,522,605, issued on Jan. 13, was assigned to Relay Therapeutics Inc. (Cambridge, Mass.) and D. E. Shaw Research LLC (New York).
"FGFR inhibitors and methods of use thereof" was invented by Bakary-Barry Toure (Cambridge, Mass.), Heike Schoenherr (Cambridge, Mass.), Alexander M. Taylor (Cambridge, Mass.), Fabrizio Giordanetto (New York), Demetri T. Moustakas (Cambridge, Mass.), Thomas H. McLean (Cambridge, Mass.), Brandi M. Hudson (Cambridge, Mass.), Mary M. Mader (Cambridge, Mass.), Pelin Ayaz (New York), Dina A. Sharon (New York), Ravi Kurukulasuriya (Cambridge, Mass.) and Alessandro Boezio (Cambridge, Mass.).
According to the abstract* released by the U.S. Patent & Trademark Office: ...